Author | Gopal H. Badlani, MD


Overactive bladder: Another agent attempts a step forward

September 03, 2020

Gopal H. Badlani, MD, discusses the recently presented long-term safety profile of the β-3 adrenoceptor agonist vibegron.

Leadership tips for your urology unit during the COVID crisis

April 01, 2020

"We take online training for simulation of chemical spill, radiation, and infection, but there is no manual to follow in this burgeoning COVID-19 crisis," writes Gopal H. Badlani, MD.

Alternatives to TURP: Consider these variables

March 13, 2020

"My conclusion is to do what you know best, learn a new technology from an expert, and consider participating in a clinical trial,” writes Gopal H. Badlani, MD.

Are reusable catheters safe? Study provides an answer

October 30, 2019

"Patient perception is an important aspect of developing an effective treatment plan, and we should be able to arm patients with accurate data to help them make an informed decision," write Whitney Renee Smith, MD, and Gopal H. Badlani, MD.